Business Context and Reporting Period
This Form 8-K Current Report was filed by iBio, Inc. on August 26, 2021. The company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol IBIO. The report addresses a specific corporate governance event rather than periodic financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding personnel changes and does not contain financial statements or operational metrics.
Material Changes
The material change reported is the resignation of Seymour Flug as a director of iBio, Inc., effective August 26, 2021. The company explicitly stated that the resignation was not the result of any disagreement between the director and the company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific event of the director's departure.
Key Facts for Investor Verification
- Seymour Flug resigned as a director on August 26, 2021.
- The resignation was not caused by any disagreement with the company.
- Thomas F. Isett, Chief Executive Officer, signed the report on August 31, 2021.
- No financial data or operational metrics are included in this specific filing.